$AMPX
Amprius Technologies, Inc. Stock $ampx

$ampx Overview Financials Valuation SEC Filings Company Website

2024 Q2 Form 10-Q Financial Statement

#000189928724000048 Filed on May 09, 2024

Income Statement

Concept	2024 Q2	2024 Q1	2023 Q1
Revenue	$3.345M	$2.336M	$679.0K
YoY Change	104.96%	244.04%	-67.82%
Cost Of Revenue	$9.876M	$6.781M	$4.104M
YoY Change	111.75%	65.23%	30.33%
Gross Profit	-$6.531M	-$4.445M	-$3.425M
YoY Change	115.4%	29.78%	229.64%
Gross Profit Margin	-195.25%	-190.28%	-504.42%
Selling, General & Admin	$4.739M	$4.293M	$5.526M
YoY Change	-24.53%	-22.31%	267.91%
% of Gross Profit
Research & Development	$1.662M	$1.581M	$800.0K
YoY Change	115.28%	97.63%	116.8%
% of Gross Profit
Depreciation & Amortization	$1.100M	$1.017M	$400.0K
YoY Change	120.0%	154.25%	19.76%
% of Gross Profit
Operating Expenses	$6.401M	$5.874M	$6.326M
YoY Change	-9.22%	-7.15%	238.11%
Operating Profit	-$12.93M	-$10.32M	-$9.751M
YoY Change	28.26%	5.83%	8423.3%
Interest Expense			$650.0K
YoY Change
% of Operating Profit
Other Income/Expense, Net	$415.0K	$433.0K	$649.0K
YoY Change	-34.65%	-33.28%	-558.88%
Pretax Income			-$9.102M
YoY Change			216.26%
Income Tax		$0.00	$0.00
% Of Pretax Income
Net Earnings	-$12.50M	-$9.900M	-$9.100M
YoY Change	32.98%	8.79%	3456.98%
Net Earnings / Revenue	-373.69%	-423.8%	-1340.21%
Basic Earnings Per Share	-$0.13	-$0.11	-$0.11
Diluted Earnings Per Share	-$0.13	-$0.11	-$0.11
COMMON SHARES
Basic Shares Outstanding	94.47M shares	91.60M shares	84.63M shares
Diluted Shares Outstanding	97.05M shares	90.03M shares	84.65M shares

Balance Sheet

Concept	2024 Q2	2024 Q1	2023 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments			$64.19M
YoY Change			644.97%
Cash & Equivalents	$46.40M	$39.00M	$64.20M
Short-Term Investments
Other Short-Term Assets			$4.316M
YoY Change			235.35%
Inventory	$1.527M	$858.0K	$845.0K
Prepaid Expenses
Receivables	$1.700M	$1.400M	$600.0K
Other Receivables			$0.00
Total Short-Term Assets	$53.04M	$45.62M	$69.90M
YoY Change	-24.97%	-34.73%	2229.34%
LONG-TERM ASSETS
Property, Plant & Equipment	$23.95M	$22.94M	$4.948M
YoY Change	246.94%	363.58%	-27.93%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$1.476M	$1.466M	$684.0K
YoY Change	110.26%	114.33%	668.54%
Total Long-Term Assets	$59.72M	$59.06M	$14.05M
YoY Change	274.7%	320.53%	-93.89%
TOTAL ASSETS
Total Short-Term Assets	$53.04M	$45.62M	$69.90M
Total Long-Term Assets	$59.72M	$59.06M	$14.05M
Total Assets	$112.8M	$104.7M	$83.95M
YoY Change	30.15%	24.7%	-63.98%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$4.490M	$1.992M	$1.023M
YoY Change	652.09%	94.72%	1338.05%
Accrued Expenses	$3.269M	$3.431M	$3.665M
YoY Change	-54.22%	-6.38%	2358.03%
Deferred Revenue	$3.151M	$3.243M	$3.135M
YoY Change	-1.47%	3.44%
Short-Term Debt			$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$12.83M	$9.762M	$8.884M
YoY Change	6.83%	9.88%	3933.76%
LONG-TERM LIABILITIES
Long-Term Debt			$0.00
YoY Change
Other Long-Term Liabilities			$8.029M
YoY Change			161.7%
Total Long-Term Liabilities			$8.029M
YoY Change			161.7%
TOTAL LIABILITIES
Total Short-Term Liabilities	$12.83M	$9.762M	$8.884M
Total Long-Term Liabilities			$8.029M
Total Liabilities	$47.63M	$44.75M	$16.91M
YoY Change	138.78%	164.6%	-29.73%
SHAREHOLDERS EQUITY
Retained Earnings	-$152.1M	-$139.5M	-$102.0M
YoY Change	36.54%	36.76%	384.84%
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$65.13M	$59.94M	$67.04M
YoY Change
Total Liabilities & Shareholders Equity	$112.8M	$104.7M	$83.95M
YoY Change	30.15%	24.7%	-63.98%

Cashflow Statement

Concept	2024 Q2	2024 Q1	2023 Q1
OPERATING ACTIVITIES
Net Income	-$12.50M	-$9.900M	-$9.100M
YoY Change	32.98%	8.79%	3456.98%
Depreciation, Depletion And Amortization	$1.100M	$1.017M	$400.0K
YoY Change	120.0%	154.25%	19.76%
Cash From Operating Activities		-$9.779M	-$6.492M
YoY Change		50.63%	1470.09%
INVESTING ACTIVITIES
Capital Expenditures		$3.896M	$1.140M
YoY Change		241.75%	-3452.94%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities		-$3.896M	-$1.140M
YoY Change		241.75%	-99.5%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities		$8.159M	$2.123M
YoY Change		284.31%	-99.09%
NET CHANGE
Cash From Operating Activities		-$9.779M	-$6.492M
Cash From Investing Activities		-$3.896M	-$1.140M
Cash From Financing Activities		$8.159M	$2.123M
Net Change In Cash		-$5.516M	-$5.509M
YoY Change		0.13%	-314.04%
FREE CASH FLOW
Cash From Operating Activities		-$9.779M	-$6.492M
Capital Expenditures		$3.896M	$1.140M
Free Cash Flow		-$13.68M	-$7.632M
YoY Change		79.18%	1911.17%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2024Q1	us-gaap	Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1 RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1	P4Y
CY2023Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2024Q1	us-gaap	Cost Of Revenue CostOfRevenue	6781000	usd
CY2023Q1	us-gaap	Cost Of Revenue CostOfRevenue	4196000	usd
CY2024Q1	us-gaap	Gross Profit GrossProfit	-4445000	usd
CY2023Q1	us-gaap	Gross Profit GrossProfit	-3517000	usd
CY2024Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	1581000	usd
CY2023Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	800000	usd
CY2024Q1	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	4293000	usd
CY2023Q1	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	5434000	usd
CY2024Q1	us-gaap	Operating Expenses OperatingExpenses	5874000	usd
CY2023Q1	us-gaap	Operating Expenses OperatingExpenses	6234000	usd
CY2024Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-10319000	usd
CY2023Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-9751000	usd
CY2024Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	433000	usd
CY2023Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	649000	usd
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	-9886000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-9102000	usd
CY2024Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	90029320	shares
CY2024Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	90029320	shares
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	84645097	shares
CY2023Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	84645097	shares
CY2024Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.11
CY2024Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.11
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.11
CY2023Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.11
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	59800000	usd
CY2024Q1	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	8746000	usd
CY2024Q1	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	28000	usd
CY2024Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	1247000	usd
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	-9886000	usd
CY2024Q1	us-gaap	Stockholders Equity StockholdersEquity	59935000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	73033000	usd
CY2023Q1	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	2376000	usd
CY2023Q1	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	2000	usd
CY2023Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	726000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-9102000	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	67035000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-9102000	usd
CY2024Q1	us-gaap	Share Based Compensation ShareBasedCompensation	1247000	usd
CY2023Q1	us-gaap	Share Based Compensation ShareBasedCompensation	726000	usd
CY2024Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	1017000	usd
CY2023Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	416000	usd
CY2024Q1	us-gaap	Other Amortization Of Deferred Charges OtherAmortizationOfDeferredCharges	0	usd
CY2023Q1	us-gaap	Other Amortization Of Deferred Charges OtherAmortizationOfDeferredCharges	134000	usd
CY2024Q1	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	1286000	usd
CY2023Q1	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	202000	usd
CY2024Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	177000	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-131000	usd
CY2024Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	128000	usd
CY2023Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	345000	usd
CY2024Q1	us-gaap	Increase Decrease In Deferred Charges IncreaseDecreaseInDeferredCharges	148000	usd
CY2023Q1	us-gaap	Increase Decrease In Deferred Charges IncreaseDecreaseInDeferredCharges	864000	usd
CY2024Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	719000	usd
CY2023Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-553000	usd
CY2024Q1	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	-9000	usd
CY2023Q1	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	0	usd
CY2024Q1	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	352000	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	59000	usd
CY2024Q1	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	-2163000	usd
CY2023Q1	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	1120000	usd
CY2024Q1	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	-191000	usd
CY2023Q1	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	657000	usd
CY2024Q1	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-278000	usd
CY2023Q1	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-179000	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-9779000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-6492000	usd
CY2024Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	3896000	usd
CY2023Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	1140000	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-3896000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-1140000	usd
CY2024Q1	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	0	usd
CY2023Q1	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	268000	usd
CY2024Q1	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	28000	usd
CY2023Q1	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	2000	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	8159000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	2123000	usd
CY2024Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-5516000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-5509000	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	45817000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	69752000	usd
CY2024Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	40301000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	64243000	usd
CY2024Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	39045000	usd
CY2023Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	64187000	usd
CY2024Q1	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	1256000	usd
CY2023Q1	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	56000	usd
CY2024Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	40301000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	64243000	usd
CY2024Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	39000000	usd
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	-9900000	usd
CY2024Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-139500000	usd
CY2024Q1	us-gaap	Prior Period Reclassification Adjustment Description PriorPeriodReclassificationAdjustmentDescription	<div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Reclassification</span></div><div style="margin-top:10pt;text-indent:25.2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain accounts in the prior period condensed consolidated statements of operations were reclassified to conform with the current period presentation. The reclassification had no impact on our prior period consolidated balance sheet, net loss and cash flows.</span></div>
CY2024Q1	us-gaap	Use Of Estimates UseOfEstimates	<div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="margin-top:10pt;text-indent:25.2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosures of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. These estimates are based on current facts, historical experience and various other factors believed to be reasonable under the circumstances; the results of which form the basis for making judgements that are not readily apparent from other sources. Actual results could materially differ from management estimates using different assumptions or under different conditions. </span></div><div style="margin-top:10pt;text-indent:25.2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our significant accounting estimates include useful lives of property, plant and equipment; valuation of deferred taxes; lower of cost or net realizable adjustment of inventory; incremental borrowing rate used in calculating lease obligations and right-of-use assets; and certain inputs used to measure fair value of stock option grants using the Black-Scholes option-pricing model.</span></div>
CY2024Q1	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	1300000	usd
CY2023Q4	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	56000	usd
CY2024Q1	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Concentration of Credit Risk</span></div>Financial instruments that potentially subject us to concentration of credit risk include cash, cash equivalents, restricted cash equivalents and accounts receivable. Through March 31, 2024, we have not experienced losses on our financial assets held in financial institutions and on our accounts receivable.
CY2024Q1	us-gaap	Revenues Revenues	2336000	usd
CY2023Q1	us-gaap	Revenues Revenues	679000	usd
CY2024Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	1400000	usd
CY2023Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	1300000	usd
CY2023Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	700000	usd
CY2024Q1	us-gaap	Contract With Customer Asset Net ContractWithCustomerAssetNet	0	usd
CY2023Q4	us-gaap	Contract With Customer Asset Net ContractWithCustomerAssetNet	0	usd
CY2024Q1	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	3200000	usd
CY2023Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	3400000	usd
CY2023Q1	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	3400000	usd
CY2024Q1	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	500000	usd
CY2023Q1	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	100000	usd
CY2024Q1	us-gaap	Revenue Remaining Performance Obligation RevenueRemainingPerformanceObligation	14000000	usd
CY2024Q1	us-gaap	Revenue Remaining Performance Obligation RevenueRemainingPerformanceObligation	12600000	usd
CY2024Q1	us-gaap	Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1 RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1	P1Y
CY2024Q1	us-gaap	Revenue Remaining Performance Obligation RevenueRemainingPerformanceObligation	1400000	usd
CY2024Q1	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	172000	usd
CY2023Q4	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	172000	usd
CY2024Q1	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	196000	usd
CY2023Q4	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	113000	usd
CY2024Q1	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	490000	usd
CY2023Q4	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	445000	usd
CY2024Q1	us-gaap	Inventory Net InventoryNet	858000	usd
CY2023Q4	us-gaap	Inventory Net InventoryNet	730000	usd
CY2024Q1	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	33005000	usd
CY2023Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	30810000	usd
CY2024Q1	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	10067000	usd
CY2023Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	9050000	usd
CY2024Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	22938000	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	21760000	usd
CY2024Q1	us-gaap	Depreciation Depreciation	1000000	usd
CY2023Q1	us-gaap	Depreciation Depreciation	400000	usd
CY2024Q1	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	1663000	usd
CY2023Q4	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	1703000	usd
CY2024Q1	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	1452000	usd
CY2023Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	3070000	usd
CY2024Q1	ampx	Accrued Purchases Of Property And Equipment AccruedPurchasesOfPropertyAndEquipment	70000	usd
CY2023Q4	ampx	Accrued Purchases Of Property And Equipment AccruedPurchasesOfPropertyAndEquipment	447000	usd
CY2024Q1	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	246000	usd
CY2023Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	374000	usd
CY2024Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	3431000	usd
CY2023Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	5594000	usd
CY2024Q1	ampx	Shares Authorized SharesAuthorized	1000000000	shares
CY2024Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	950000000	shares
CY2024Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2024Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	50000000	shares
CY2024Q1	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2024Q1	us-gaap	Class Of Warrant Or Right Number Of Securities Called By Each Warrant Or Right ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight	1	shares
CY2024Q1	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized	4800000	usd
CY2024Q1	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	47720736	shares
CY2022Q1	us-gaap	Class Of Warrant Or Right Number Of Securities Called By Each Warrant Or Right ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight	1	shares
CY2022Q1	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	11.50
CY2024Q1	ampx	Sale Of Stock Deferred Stock Issuance Cost SaleOfStockDeferredStockIssuanceCost	200000	usd
CY2024Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	1247000	usd
CY2023Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	726000	usd
CY2024Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd
CY2023Q4	ampx	Lessee Finance Lease Number Of Leases LesseeFinanceLeaseNumberOfLeases	0	lease
CY2024Q1	us-gaap	Operating Lease Cost OperatingLeaseCost	1286000	usd
CY2023Q1	us-gaap	Operating Lease Cost OperatingLeaseCost	202000	usd
CY2024Q1	us-gaap	Variable Lease Cost VariableLeaseCost	111000	usd
CY2023Q1	us-gaap	Variable Lease Cost VariableLeaseCost	53000	usd
CY2024Q1	us-gaap	Short Term Lease Cost ShortTermLeaseCost	22000	usd
CY2023Q1	us-gaap	Short Term Lease Cost ShortTermLeaseCost	19000	usd
CY2024Q1	us-gaap	Lease Cost LeaseCost	1419000	usd
CY2023Q1	us-gaap	Lease Cost LeaseCost	274000	usd
CY2024Q1	us-gaap	Operating Lease Payments OperatingLeasePayments	278000	usd
CY2023Q1	us-gaap	Operating Lease Payments OperatingLeasePayments	179000	usd
CY2024Q1	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	0	usd
CY2023Q1	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	5241000	usd
CY2024Q1	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P14Y2M12D
CY2023Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P9Y3M18D
CY2024Q1	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.094
CY2023Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.079
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Remainder Of Fiscal Year LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear	849000	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	1794000	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	4377000	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	5025000	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	5185000	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Five LesseeOperatingLeaseLiabilityPaymentsDueYearFive	5344000	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Due After Year Five LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive	48440000	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	71014000	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	34928000	usd
CY2024Q1	us-gaap	Operating Lease Liability OperatingLeaseLiability	36086000	usd
CY2024Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-9886000	usd
CY2024Q1	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-9886000	usd
CY2023Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-9102000	usd
CY2023Q1	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-9102000	usd
CY2024Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	90029320	shares
CY2024Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	90029320	shares
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	84645097	shares
CY2023Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	84645097	shares
CY2024Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.11
CY2024Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.11
CY2023Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.11
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.11
CY2024Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	64405731	shares
CY2023Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	61986915	shares
CY2024Q1	ecd	Non Rule10b51 Arr Adopted Flag NonRule10b51ArrAdoptedFlag	false
CY2024Q1	ecd	Rule10b51 Arr Adopted Flag Rule10b51ArrAdoptedFlag	false
CY2024Q1	ecd	Non Rule10b51 Arr Trmntd Flag NonRule10b51ArrTrmntdFlag	false

Files In Submission

Name	View Source	Status
Financial_Report.xlsx	Edgar Link	pending
0001899287-24-000048-index-headers.html	Edgar Link	pending
0001899287-24-000048-index.html	Edgar Link	pending
0001899287-24-000048.txt	Edgar Link	pending
0001899287-24-000048-xbrl.zip	Edgar Link	pending
ampx-20240331.htm	Edgar Link	pending
ampx-20240331.xsd	Edgar Link	pending
ampx-20240331xexhibit311.htm	Edgar Link	pending
ampx-20240331xexhibit312.htm	Edgar Link	pending
ampx-20240331xexhibit321.htm	Edgar Link	pending
ampx-20240331xexhibit322.htm	Edgar Link	pending
ampx-20240331_cal.xml	Edgar Link	unprocessable
ampx-20240331_def.xml	Edgar Link	unprocessable
ampx-20240331_lab.xml	Edgar Link	unprocessable
ampx-20240331_pre.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
ampx-20240331_htm.xml	Edgar Link	completed
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$AMPX
Amprius Technologies, Inc. Stock $ampx

2024 Q2 Form 10-Q Financial Statement

#000189928724000048 Filed on May 09, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$AMPX Amprius Technologies, Inc. Stock $ampx

2024 Q2 Form 10-Q Financial Statement

#000189928724000048 Filed on May 09, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$AMPX
Amprius Technologies, Inc. Stock $ampx